News

CNN News Coverage and FIND Presentation on Rapid TB test, Xpert MTB/RIF

13 Apr 2011
by Working Group
Front Lines of TB R&D TB Diagnostics TB News Video
advocacy diagnostics innovations mdr press Video

If you are having trouble viewing, click here.

CORE Group Online Presentation about New TB Diagnostic Technology, Xpert®MTB/RI

How does it work? Where can it be used? How might it make a difference in the global effort to stop TB? Hosted online by the CORE Group Tuberculosis Working Group on March 25, 2011, this easy-to-view Elluminate session offers context and an overview of the product including its diagnostic capabilities, the technology behind it, how quickly a diagnosis can be made, what infrastructure and human resources are necessary, where WHO recommends its use, and the cost implications.

Presenter Dr. Elizabeth Talbot is an Associate Professor of Infectious Diseases and International Health at Dartmouth Hitchcock Medical Center, and Medical Scientist, FIND: Foundation for Innovative New Diagnostics,

View the 45 minute presentation from March 25, 2011 by clicking on this link.

View the slides only, without narration, by clicking on this link.

Click here for Survey Results of TB Working Group by CORE Group


More News
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023

New Tools Summit in Paris this November

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022

PAN-TB Collaboration Announces Novel TB Drug Regimens Trial

The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...